Trials / Conditions / Transformed Non-Hodgkin Lymphoma
Transformed Non-Hodgkin Lymphoma
6 registered clinical trials studyying Transformed Non-Hodgkin Lymphoma — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study of WZTL-002 CAR T-cells for Adults With Relapsed Large B-cell Lymphoma NCT06486051 | Malaghan Institute of Medical Research | Phase 2 |
| Recruiting | Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment NCT05890352 | SWOG Cancer Research Network | Phase 2 |
| Recruiting | Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem C NCT05432635 | City of Hope Medical Center | Phase 1 |
| Active Not Recruiting | A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies NCT05828589 | BeOne Medicines | Phase 1 |
| Recruiting | Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgki NCT04491370 | New York Medical College | Phase 1 / Phase 2 |
| Active Not Recruiting | Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lympho NCT03749018 | David Bond, MD | Phase 2 |